Elliptic Laboratories ASA (ELABS.OL) Financials
ELABS.OL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2025 | 336.9 million | 25.7 million |
| June 30, 2025 | 336.4 million | 30.4 million |
| March 31, 2025 | 348.6 million | 35.3 million |
| Dec. 31, 2024 | 361.0 million | 35.7 million |
ELABS.OL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2025 | -508000 | 1.4 million |
| June 30, 2025 | -16.9 million | 1.1 million |
| March 31, 2025 | 4.7 million | 489000 |
| Dec. 31, 2024 | 6.7 million | 1.3 million |
ELABS.OL Net Income
No data available :(
ELABS.OL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2025 | - | - | 13.2 million |
| June 30, 2025 | 54.7 million | 9.6 million | 14.6 million |
| March 31, 2025 | 76.8 million | 10.7 million | 15.8 million |
| Dec. 31, 2024 | 76.4 million | 10.7 million | 17.4 million |
ELABS.OL Shares Outstanding
ELABS.OL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2025 | 7.0 million | - | 2.0 million | - |
| June 30, 2025 | 7.6 million | 4.4 million | 3.2 million | 1.6 million |
| March 31, 2025 | 7.4 million | 3.7 million | 4.0 million | 2.2 million |
| Dec. 31, 2024 | 6.9 million | 3.5 million | 2.9 million | 1.6 million |
ELABS.OL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2025 | 42.3 million | 23.1 million |
| June 30, 2025 | 24.6 million | 18.3 million |
| March 31, 2025 | 26.6 million | 22.0 million |
| Dec. 31, 2024 | 47.6 million | 25.6 million |
ELABS.OL
Price: NOK2.94
52 week price:
Earnings Per Share: -0.06 NOK
P/E Ratio: -51.67
Exchange: OSL
Sector: Technology
Industry: Software - Infrastructure
Market Capitalization: 326.4 million